Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Finasteride reduces prostate size and PSA levels in young patients.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

SHPro® improved urinary symptoms and erectile function in men and is safe.

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Finasteride may reduce bleeding after TURP, but more research needed.

Finasteride and dutasteride can cause severe, lasting side effects.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Older men with postoperative urinary retention are more likely to need future bladder procedures.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Ultrasound shows 80% of Hidradenitis Suppurativa patients have abnormal hair tracts that may worsen the condition.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Men with urinary issues often don't stick to their medication long-term.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.